CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
This article was originally published in The Gray Sheet
Executive Summary
CareFusion said it is evaluating a timeline for re-introducing its Alaris SE infusion pump after FDA recently informed the firm it has lifted an injunction barring sales of the devices in the U.S